Acuta Capital Partners’s Dermira, Inc. DERM Stock Holding History

Acuta Capital Partners’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-636,500	Closed	-$8.63M	–	42
2019 Q1	$8.63M	Buy	+636,500	New	+$5.31M	4.1%	9
2017 Q1	–	Sell	-88,500	Closed	-$2.68M	–	82
2016 Q4	$2.68M	Sell	88,500 -18,500	-17%	-$596K	1%	24
2016 Q3	$3.62M	Sell	107,000 -63,000	-37%	-$2.03M	1.36%	26
2016 Q2	$4.97M	Buy	+170,000	New	+$4.69M	2.39%	14

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Acuta Capital Partners's DERM Position: Q2 2019 in Review

Acuta Capital Partners sold out of Dermira, Inc. (DERM) in Q2 2019, closing a stake of 636,500 shares — an estimated $8.63M sold.

Acuta Capital Partners first reported a position in DERM in Q2 2016 and held it in 4 quarters. The position peaked at $8.63M in Q1 2019. 135 funds tracked by Wall St. Rank hold DERM as of Q2 2019.

Acuta Capital Partners reported no remaining Dermira, Inc. position as of Q2 2019 after selling out during the quarter.
Acuta Capital Partners sold 636,500 Dermira, Inc. shares in Q2 2019, an estimated $8.63M.
Acuta Capital Partners first reported a position in Dermira, Inc. in Q2 2016 and held it in 4 quarters.
Acuta Capital Partners's Dermira, Inc. position peaked at $8.63M in Q1 2019.
135 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2019.

Based on Acuta Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.